Alto Neuroscience (ANRO) News Today $3.05 +0.12 (+4.23%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$3.00 -0.05 (-1.77%) As of 05/23/2025 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ANRO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period HC Wainwright Expects Reduced Earnings for Alto NeuroscienceAlto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Investment analysts at HC Wainwright reduced their Q2 2025 earnings per share (EPS) estimates for Alto Neuroscience in a note issued to investors on Tuesday, May 20th. HC Wainwright analyst P. Trucchio now forecasts that the company will earn ($May 24 at 7:53 AM | marketbeat.comAWM Investment Company Inc. Acquires 128,100 Shares of Alto Neuroscience, Inc. (NYSE:ANRO)AWM Investment Company Inc. boosted its holdings in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) by 22.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 687,831 shares of the company's stock afterMay 23 at 8:09 AM | marketbeat.comHC Wainwright Has Bearish Estimate for ANRO Q2 EarningsMay 23 at 1:37 AM | americanbankingnews.comPoint72 Asset Management L.P. Has $7.16 Million Position in Alto Neuroscience, Inc. (NYSE:ANRO)Point72 Asset Management L.P. increased its stake in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) by 73.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,692,153 shares of the company's stock after purchasing an additional 714,461 shares dMay 22 at 4:42 AM | marketbeat.comVestal Point Capital LP Raises Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO)Vestal Point Capital LP raised its position in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) by 40.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 915,000 shares of the company's stock after buyingMay 21, 2025 | marketbeat.comQ2 Earnings Forecast for Alto Neuroscience Issued By WedbushAlto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Stock analysts at Wedbush increased their Q2 2025 EPS estimates for Alto Neuroscience in a note issued to investors on Thursday, May 15th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($0.68) for the quMay 20, 2025 | marketbeat.comQ2 EPS Forecast for Alto Neuroscience Reduced by AnalystAlto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Analysts at William Blair lowered their Q2 2025 EPS estimates for shares of Alto Neuroscience in a research report issued to clients and investors on Thursday, May 15th. William Blair analyst M. Minter now forecasts that the company will post eaMay 20, 2025 | marketbeat.comWilliam Blair Analysts Reduce Earnings Estimates for ANROMay 20, 2025 | americanbankingnews.comQ2 Earnings Estimate for Alto Neuroscience Issued By WedbushMay 19, 2025 | americanbankingnews.comAlto Neuroscience (NYSE:ANRO) Earns Neutral Rating from WedbushMay 18, 2025 | americanbankingnews.comEquities Analysts Set Expectations for ANRO Q1 EarningsMay 18, 2025 | americanbankingnews.comAlto Neuroscience Advances Precision Psychiatry PipelineMay 16, 2025 | tipranks.comAlto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 15, 2025 | finance.yahoo.comOrbimed Advisors LLC Acquires New Position in Alto Neuroscience, Inc. (NYSE:ANRO)Orbimed Advisors LLC bought a new position in shares of Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 250,000 shares of the company's stock, valued at approximately $1,058,000. Orbimed AdvisMay 15, 2025 | marketbeat.comIntegral Health Asset Management LLC Buys New Shares in Alto Neuroscience, Inc. (NYSE:ANRO)Integral Health Asset Management LLC bought a new stake in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 300,000 shares of the company's stock, valued at approximaMay 14, 2025 | marketbeat.comStifel Financial Corp Takes $544,000 Position in Alto Neuroscience, Inc. (NYSE:ANRO)Stifel Financial Corp bought a new stake in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 128,700 shares of the company's stock, valued at approximately $544,000. StifelMay 13, 2025 | marketbeat.comAlto Neuroscience, Inc. (NYSE:ANRO) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Alto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven analysts that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and four have issued a buy recommendatiMay 12, 2025 | marketbeat.comAlto Neuroscience Stock Short Interest Report | NYSE:ANRO | BenzingaMay 10, 2025 | benzinga.comAlto Neuroscience (ANRO) Expected to Announce Quarterly Earnings on TuesdayAlto Neuroscience (NYSE:ANRO) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-alto-neuroscience-inc-stock/)May 8, 2025 | marketbeat.comCantor Fitzgerald L. P. Buys Shares of 375,000 Alto Neuroscience, Inc. (NYSE:ANRO)Cantor Fitzgerald L. P. purchased a new position in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 375,000 shares of the company's stock, valued at approximateMay 7, 2025 | marketbeat.comAlkeon Capital Management LLC Has $2.02 Million Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO)Alkeon Capital Management LLC reduced its position in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) by 49.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 477,101 shares of the company's stock after selling 457,803 shares during the period. Alkeon CapitalMay 5, 2025 | marketbeat.comAlmitas Capital LLC Takes Position in Alto Neuroscience, Inc. (NYSE:ANRO)Almitas Capital LLC purchased a new position in shares of Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 266,912 shares of the company'May 4, 2025 | marketbeat.comAlto Neuroscience Presents New Data at the Society of Biological Psychiatry Annual Meeting Underscoring Precision Psychiatry ApproachApril 28, 2025 | businesswire.comMarshall Wace LLP Makes New $3.54 Million Investment in Alto Neuroscience, Inc. (NYSE:ANRO)Marshall Wace LLP acquired a new stake in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 837,374 shares of the company's stock, valued at approximately $3,542,000. Marshall WaceApril 28, 2025 | marketbeat.comAlto Neuroscience to Participate in the JonesResearch Virtual CNS DayApril 22, 2025 | finance.yahoo.comAlto Neuroscience, Inc. (NYSE:ANRO) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesAlto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven ratings firms that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold rating and four have given a buy rating to the cApril 17, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for ANRO Q1 Earnings?Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) - HC Wainwright issued their Q1 2025 EPS estimates for shares of Alto Neuroscience in a research note issued on Monday, April 7th. HC Wainwright analyst P. Trucchio expects that the company will earn ($0.45) per share for the quarter. HC WainwrighApril 12, 2025 | marketbeat.comAlto Neuroscience (NYSE:ANRO) Now Covered by HC WainwrightHC Wainwright began coverage on Alto Neuroscience in a research report on Monday. They issued a "buy" rating and a $10.00 price target on the stock.April 9, 2025 | marketbeat.comAlto Neuroscience initiated with a Buy at H.C. WainwrightApril 8, 2025 | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of Alto Neuroscience (ANRO) with Buy RecommendationApril 8, 2025 | msn.comJonesTrading Sticks to Its Buy Rating for Alto Neuroscience, Inc. (ANRO)March 25, 2025 | markets.businessinsider.comBuy Rating Reaffirmed for Alto Neuroscience, Inc. Amid Promising Pipeline and Upcoming Data ReadoutsMarch 24, 2025 | tipranks.comWhat is Wedbush's Estimate for ANRO FY2029 Earnings?Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Stock analysts at Wedbush issued their FY2029 earnings per share estimates for Alto Neuroscience in a research report issued on Thursday, March 20th. Wedbush analyst L. Chico anticipates that the company will post earnings per share of ($2.88) fMarch 24, 2025 | marketbeat.comWhat is William Blair's Forecast for ANRO Q1 Earnings?Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Analysts at William Blair issued their Q1 2026 EPS estimates for Alto Neuroscience in a report released on Friday, March 21st. William Blair analyst M. Minter expects that the company will post earnings of ($0.53) per share for the quarter. WillMarch 24, 2025 | marketbeat.comAnalysts Offer Insights on NA Companies: Reddit Inc Class A (RDDT) and Alto Neuroscience, Inc. (ANRO)March 22, 2025 | markets.businessinsider.comALTO NEUROSCIENCE Earnings Results: $ANRO Reports Quarterly EarningsMarch 22, 2025 | nasdaq.comAlto Neuroscience, Inc. (ANRO) Gets a Hold from WedbushMarch 22, 2025 | markets.businessinsider.comAlto Neuroscience, Inc. (NYSE:ANRO) Given Average Rating of "Moderate Buy" by AnalystsShares of Alto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) have been given an average rating of "Moderate Buy" by the six brokerages that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have issued a buyMarch 22, 2025 | marketbeat.comAlto Neuroscience's (ANRO) Outperform Rating Reaffirmed at William BlairWilliam Blair restated an "outperform" rating on shares of Alto Neuroscience in a research note on Friday.March 22, 2025 | marketbeat.comAlto Neuroscience (NYSE:ANRO) Posts Earnings Results, Beats Expectations By $0.09 EPSAlto Neuroscience (NYSE:ANRO - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.56) earnings per share for the quarter, beating analysts' consensus estimates of ($0.65) by $0.09.March 21, 2025 | marketbeat.comAlto Neuroscience Reports Full-Year 2024 Financial Results and Recent Business HighlightsMarch 20, 2025 | gurufocus.comAlto Neuroscience (ANRO) Expected to Announce Quarterly Earnings on ThursdayAlto Neuroscience (NYSE:ANRO) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.March 13, 2025 | marketbeat.comAlto Neuroscience (NYSE:ANRO) Trading Up 8.8% - Should You Buy?Alto Neuroscience (NYSE:ANRO) Stock Price Up 8.8% - What's Next?March 6, 2025 | marketbeat.comAlto Neuroscience rises 25.0%March 4, 2025 | markets.businessinsider.com1 ‘Strong Buy’ Penny Stock With 270% Upside to Load Up On in MarchMarch 4, 2025 | msn.comAlto Neuroscience rises 19.6%March 3, 2025 | markets.businessinsider.comAlto Neuroscience to Participate in Upcoming Investor ConferencesFebruary 25, 2025 | businesswire.comUSPTO grants Alto Neuroscience patent for MDD treatment covering ALTO-300February 19, 2025 | markets.businessinsider.comAlto Neuroscience Announces U.S. Patent Granted Covering ALTO-300 as a Treatment for Patients with Major Depressive Disorder Characterized by an Electroencephalogram BiomarkerFebruary 19, 2025 | businesswire.comPleasing Signs As A Number Of Insiders Buy Alto Neuroscience StockFebruary 18, 2025 | finance.yahoo.com Get Alto Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter. Email Address ANRO Media Mentions By Week ANRO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANRO News Sentiment▼0.540.77▲Average Medical News Sentiment ANRO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANRO Articles This Week▼182▲ANRO Articles Average Week Get Alto Neuroscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Cartesian Therapeutics News Today 2seventy bio News Today Alumis News Today Inozyme Pharma News Today Monte Rosa Therapeutics News Today Terns Pharmaceuticals News Today Palvella Therapeutics News Today Lifecore Biomedical News Today Tango Therapeutics News Today Gossamer Bio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ANRO) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ANRO Stock Free ANRO Stock Alerts